CDC Newsroom
FDA Media Briefing: Janssen COVID-19 Vaccine
A joint media briefing with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine.
Tuesday, Apr. 13 at 10:00 a.m. ET
Transcripts will be posted as soon as they are available.
Latest News Releases
- Transgender Women Urgently Need More HIV Prevention and Treatment Services, New CDC Data Show Thursday, April 15, 2021
- Reported STDs Reach All-time High for 6th Consecutive Year Tuesday, April 13, 2021
- FDA Media Briefing: Janssen COVID-19 Vaccine Tuesday, April 13, 2021
- Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine Tuesday, April 13, 2021
- Media Statement from CDC Director Rochelle P. Walensky, MD, MPH, on Racism and Health Thursday, April 8, 2021
- Federal Grantees May Now Use Funds to Purchase Fentanyl Test Strips Wednesday, April 7, 2021
- CDC Awards $3 Billion to Expand COVID-19 Vaccine Programs Wednesday, April 7, 2021
- Nearly 80 percent of teachers, school staff, and childcare workers receive at least one shot of COVID-19 vaccine Tuesday, April 6, 2021
Digital Gallery
1
2
CDC Center Newsrooms
- National Center for Environmental Health
- National Center for Health Statistics
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
- National Center for Injury Prevention and Control
- National Institute for Occupational Safety and Health (NIOSH)
- Center for Global Health
- National Center for Emerging and Zoonotic Infectious Diseases
CDC Spokespersons
email_03Updates
Sign up for email updates related to CDC news and events.
Relevant Links
Page last reviewed: March 31, 2021
Content source: Centers for Disease Control and Prevention